Concepedia

Harald Weinstabl

HW

29

Publications

2.4K

Citations

24

H-Index

2007

Active since

Affiliations

Boehringer Ingelheim (Austria)(Current)

University of Toronto

Boehringer Ingelheim (Germany)

University of Dundee

University of Vienna

Harald Weinstabl is an author at Boehringer Ingelheim (Austria) specializing in natural sciences, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2007–2024

29

Publications

29

BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design

William Farnaby, Manfred Koegl, Michael J. Roy et al. · Nature Chemical Biology · 2019 · 553 citations · Full text

, , +10

A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo

Christiane Kofink, Nicole Trainor, Barbara Mair et al. · Nature Communications · 2022 · 194 citations · Full text

BacPROTACs mediate targeted protein degradation in bacteria

Francesca Morreale, Stefan Kleine, Julia Leodolter et al. · Cell · 2022 · 165 citations · Full text

Total Synthesis of (+)‐Linoxepin by Utilizing the Catellani Reaction

Harald Weinstabl, Marcel Suhartono, Zafar Qureshi et al. · Angewandte Chemie International Edition · 2013 · 139 citations · Full text

, , +14

Targeting cancer with small-molecule pan-KRAS degraders

Johannes Popow, William Farnaby, Andreas Gollner et al. · Science · 2024 · 130 citations · Full text

, , +15

Rows per page

1–5 of 29